University Hospitals Harrington Heart & Vascular Institute's Avatar

University Hospitals Harrington Heart & Vascular Institute

@harringtonhvi.bsky.social

News from University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio. Nationally recognized expertise and innovations @uhcleveland.bsky.social #cardiosky #vascsky

32 Followers  |  7 Following  |  5 Posts  |  Joined: 28.04.2025  |  1.6877

Latest posts by harringtonhvi.bsky.social on Bluesky

Post image

Don’t miss it! Hands-on training, live cases, debates and more at the Inaugural Cleveland Aortic Symposium: The Root, The Arch, The Works

View Agenda
cwru.cloud-cme.com/Assets/cwru/...

Register Online & Learn More
cwru.cloud-cme.com/course/cours...

13.08.2025 17:08 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
UH Receives Highest Designation for Quality Outcomes for Coronary Artery Bypass Grafting 3-star recognition from the Society of Thoracic Surgeons.

The Society of Thoracic Surgeons has awarded @harringtonhvi.bsky.social a 3-star rating, its highest designation, for CABG quality outcomes. Only 20% of hospitals nationally have a 3-star rating. @uhcleveland.bsky.social @sts.org #cardiosky
news.uhhospitals.org/news-release...

07.07.2025 16:09 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Excited to share that my colleagues, Drs Robert Goldstein and Samer de Oliveira, at UH Lake West Hospital are performing Pulsed Field Ablation to treat Afib! @harringtonhvi.bsky.social
@nejm.org nejm.org/doi/full/10.1056/NEJMoa2502280

03.06.2025 13:26 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
UH First Site in Ohio to Provide More Accurate and Convenient PET MPI Cardiac Stress Test First-of-its-kind F 18 radiopharmaceutical helps physicians better detect blockages in heart arteries that can lead to heart attacks.

First in Ohio to clinically administer FDA-approved PET MPI agent Flyrcado (flurpiridaz F 18) injection in patients with known or suspected CAD. β€œOne of the most groundbreaking advancements in nuclear cardiology in decades.” #cardiosky

news.uhhospitals.org/news-release...

01.07.2025 12:25 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Novel Aspiration Thrombectomy and Blood Reinfusion System for Acute Intermediate-Risk Pulmonary Embolism: AVENTUS Trial Results Mechanical thrombectomy has become a first-line adjunctive therapy for anticoagulation in patients with acute intermediate-risk pulmonary embolism (PE). This prospective study evaluated the safety and...

"An important advancement in PE care.” – Dr. Jun Li, Co-Director, Vascular Center @harringtonhvi.bsky.social and national co-PI of Inquis Medical’s AVENTUS thrombectomy system shared trial results at @scainews.bsky.social Scientific Sessions @uhreinstitute.bsky.social www.jscai.org/article/S277...

08.05.2025 12:26 β€” πŸ‘ 3    πŸ” 4    πŸ’¬ 1    πŸ“Œ 1
Post image Post image

Congratulations Dr Varun Sundaram! Transform-AF presented as a LBCT- demonstrated impact of SGLP-1 on reducing AF with just modest weight loss. A potential gamechanger! TOP 3 #HRS2025 Pacesetter Pick. Saksena commentary β€œtransformative”. @harringtonhvi.bsky.social @heartrhythmsociety.bsky.social

28.04.2025 13:09 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image

UH Harrington HVI Reunion @HeartRhythm2025
What a night! Alumni/Faculty/Fellows spanning 40 years of EP at UH!!! RIP ALW

28.04.2025 12:42 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Preview
Trials at University Hospitals Harrington Heart & Vascular Institute Advance Leadless Pacemakers and Extravascular ICDs | Cleveland, Ohio Innovations in Cardiovascular Medicine & Surgery | March 2025

Extravascular ICDs can address limitations of transvenous ICDs, providing effective defibrillation with improved pacing capabilities. Two investigational exemption trials helped bring novel options to market. @judymackall.bsky.social #cardiosky

www.uhhospitals.org/for-clinicia...

28.04.2025 12:20 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

@harringtonhvi is following 7 prominent accounts